rs1518110

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000572.3(IL10):​c.166-101T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 971,306 control chromosomes in the GnomAD database, including 270,706 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.70 ( 38315 hom., cov: 30)
Exomes 𝑓: 0.74 ( 232391 hom. )

Consequence

IL10
NM_000572.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.590

Publications

59 publications found
Variant links:
Genes affected
IL10 (HGNC:5962): (interleukin 10) The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020]
IL19 (HGNC:5990): (interleukin 19) The protein encoded by this gene is a cytokine that belongs to the IL10 cytokine subfamily. This cytokine is found to be preferentially expressed in monocytes. It can bind the IL20 receptor complex and lead to the activation of the signal transducer and activator of transcription 3 (STAT3). A similar cytokine in mouse is reported to up-regulate the expression of IL6 and TNF-alpha and induce apoptosis, which suggests a role of this cytokine in inflammatory responses. Alternatively spliced transcript variants encoding the distinct isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-206771516-A-C is Benign according to our data. Variant chr1-206771516-A-C is described in ClinVar as Benign. ClinVar VariationId is 2628131.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.785 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL10NM_000572.3 linkc.166-101T>G intron_variant Intron 1 of 4 ENST00000423557.1 NP_000563.1 P22301Q6FGW4
IL19NM_153758.5 linkc.-149+438A>C intron_variant Intron 1 of 6 ENST00000659997.3 NP_715639.2 Q9UHD0-1
IL19NM_001393490.1 linkc.-149+686A>C intron_variant Intron 1 of 6 NP_001380419.1
IL10NR_168466.1 linkn.225-101T>G intron_variant Intron 1 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL10ENST00000423557.1 linkc.166-101T>G intron_variant Intron 1 of 4 1 NM_000572.3 ENSP00000412237.1 P22301
IL19ENST00000659997.3 linkc.-149+438A>C intron_variant Intron 1 of 6 NM_153758.5 ENSP00000499459.2 Q9UHD0-1

Frequencies

GnomAD3 genomes
AF:
0.701
AC:
106316
AN:
151668
Hom.:
38290
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.591
Gnomad AMI
AF:
0.707
Gnomad AMR
AF:
0.682
Gnomad ASJ
AF:
0.755
Gnomad EAS
AF:
0.318
Gnomad SAS
AF:
0.581
Gnomad FIN
AF:
0.808
Gnomad MID
AF:
0.699
Gnomad NFE
AF:
0.791
Gnomad OTH
AF:
0.685
GnomAD4 exome
AF:
0.743
AC:
609056
AN:
819520
Hom.:
232391
AF XY:
0.739
AC XY:
314185
AN XY:
425170
show subpopulations
African (AFR)
AF:
0.596
AC:
12125
AN:
20330
American (AMR)
AF:
0.628
AC:
21352
AN:
33974
Ashkenazi Jewish (ASJ)
AF:
0.775
AC:
16711
AN:
21558
East Asian (EAS)
AF:
0.336
AC:
11198
AN:
33316
South Asian (SAS)
AF:
0.617
AC:
40638
AN:
65880
European-Finnish (FIN)
AF:
0.802
AC:
38245
AN:
47666
Middle Eastern (MID)
AF:
0.734
AC:
3008
AN:
4100
European-Non Finnish (NFE)
AF:
0.790
AC:
437645
AN:
553948
Other (OTH)
AF:
0.726
AC:
28134
AN:
38748
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
7688
15375
23063
30750
38438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6860
13720
20580
27440
34300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.701
AC:
106401
AN:
151786
Hom.:
38315
Cov.:
30
AF XY:
0.697
AC XY:
51698
AN XY:
74162
show subpopulations
African (AFR)
AF:
0.592
AC:
24475
AN:
41350
American (AMR)
AF:
0.681
AC:
10397
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.755
AC:
2620
AN:
3472
East Asian (EAS)
AF:
0.318
AC:
1643
AN:
5164
South Asian (SAS)
AF:
0.580
AC:
2788
AN:
4804
European-Finnish (FIN)
AF:
0.808
AC:
8496
AN:
10514
Middle Eastern (MID)
AF:
0.694
AC:
204
AN:
294
European-Non Finnish (NFE)
AF:
0.791
AC:
53685
AN:
67910
Other (OTH)
AF:
0.687
AC:
1451
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1522
3044
4566
6088
7610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.735
Hom.:
5353
Bravo
AF:
0.686
Asia WGS
AF:
0.498
AC:
1737
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 69% of patients studied by a panel of primary immunodeficiencies. Number of patients: 66. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.3
DANN
Benign
0.38
PhyloP100
-0.59
PromoterAI
-0.032
Neutral
Mutation Taster
=20/80
disease causing (long InDel)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1518110; hg19: chr1-206944861; API